The IMPROVEMENT study (IMprovement PROgram in eValuation and managEMENT of heart failure) - Rationale and design;Załozenia programu IMPROVEMENT (IMprovement PROgram in eValuation and managEMENT of heart failure)

Folia Cardiologica

Volumn 10, Issue 1, 2003, Pages 23-28

  Korewicki, Jerzy ^a   Tendera, Michał ^b   Browarek, Aldona ^a   Zieliński, Tomasz ^a   Cleland, J G F ^d   Cohen Solal, A ^d   Cosin Aguilar, J ^d   Dietz, R ^d   Eastaugh, J ^d   Follath, F ^d   Freemantle, N ^d   Gavazzi, A ^d   van Gilst, W H ^d   Hobbs, F D R ^d   Korewicki, J ^d   Madeira, H C ^d   Preda, I ^d   Swedberg, K ^d   Widimski, J ^d   Cieslinski A ^c   Dabrowski, M ^c   Kornacewicz Jach, Z ^c   Krzeminska Pakula M ^c   Opolski, G ^c   Polonski L ^c   Rynkiewicz, A ^c   Wrabec, K ^c   Wysocki, H ^c   more..

^a Klinika Niewydolnosci Serca   (Poland)

^b Gornoslaskie Centrum Medyczne   (Poland)

^c Koordynatorzy Reg Prog IMPROVEMENT   (Poland)

^d NONE

Author keywords

Heart failure; IMPROVEMENT; Primary care physician

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; DATA BASE; DIABETES MELLITUS; DYSPNEA; EDUCATION PROGRAM; EUROPE; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SOCIETY; PRIMARY MEDICAL CARE; SEX DIFFERENCE; SYMPTOMATOLOGY; URBAN AREA; VALVULAR HEART DISEASE;

EID: 0037257636     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Task force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology: Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 2001; 22: 1527-1560.
2. Boersma E., Manini M., Wood D.A., Bassand J.P., Simoons M.L. (red.). Cardiovascular diseases in Europe. Euro Heart Survey and National Registries of Cardiovascular Diseases and Patient Management 2002. European Society of Cardiology. Sophia, Antipolis, 2002.
3. Rywik S.L., Wagrowska H., Broda G. i wsp. Heart failure in outpatients clinics. Cz. I: General characteristics. Eur. J. Heart Failure 2000; 2: 413-421.
4. Korewicki J., Rywik S., Rywik T. Management of heart failure patients in Poland. Eur. J. Heart Failure 2002; 4: 215-219.
5. Cleland J.G.F., Sharpe N., Doughty R. i wsp. Heart Failure. Lancet 1998; 352: 1-41.
6. Ho K.K.L., Anderson K.M., Kannel W.B. i wsp. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115.
7. McKee P.A., Castelli W.P., Mc Namara, Kamel W.B. The natural history of congestive heart failure: the Framingham Study. N. Eng. J. Med. 1971; 285: 1441-1446.
8. Cowie M.R., Mosterd A., Wood D.A. i wsp. The epidemiology of heart failure. Eur. Heart J. 1997; 18: 208-225.
9. Rywik S., Broda G., Jasiński B. Niewydolność serca - umieralność i chorobowość szpitalna ludności Polski. Kard. Pol. 1999; 50: 20-34.
10. Clarke K.W., Gray D., Hampton J.R. Evidence of inadequate investigation and treatment of patients with heart failure. Br. Heart J. 1994; 71: 584-587.
11. Vasan R.S., Benjamin E.J. Diastolic: heart failure - no time to relax. N. Eng. J. Med. 2001; 344: 58-59.
12. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. Increasing the awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative. Eur. J. Heart Failure 1999; 1: 139-144.
13. Cleland J.G.F., Cohen-Solal A., Cosin-Aguilar J. i wsp. for the IMPROVEMENT of Heart Failure Programme Committees and Investigators and the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology: Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631-1639.